Earnings Week Dominates — Bears Dug In
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Markets face a defining 48 hours. Over 1,800 companies report this week. The positioning data tells a stark story: shorts are leaning in hard ahead of the biggest prints.
Earnings in Focus
PLTR kicks things off today after the close. AMD and CAT follow Tuesday. Wednesday brings LLY, the $1 trillion pharma leader whose GLP-1 results will set the tone for the whole sector. BKNG also reports Tuesday — and notably, short sellers have been retreating there. Bears appear to be picking their battles rather than fighting every name.
Bears Pile Into High-Risk Names
The most aggressive positioning sits in names with the most to lose. HTZ short interest hit 84.6% of free float. Availability is zero — no shares left to borrow. CHWY jumped from 72% to 82% SI in one week as bears rebuilt ahead of its print. SOUN is a squeeze setup: 43% SI, cost to borrow at 15.1% APR, and zero availability. LCID has borrow locked out entirely with options market on edge.
Analysts Cut Three Names
JCI, BMY, and ZBRA all saw downgrades on August 2. Bristol-Myers Squibb's consensus target edged down to $64.91. Meanwhile, analysts are piling into HONA — Honeywell Aerospace — ahead of its first full earnings season as a standalone company.
Macro Backdrop
The FT flagged a notable development in currency markets. The New York Fed intervened in the yen market, selling euros to buy yen. The Japanese yen jumped 3% on intervention speculation. South Korean stocks soared 18% as AI-related buying returned. SNDK heads into its print with a collapsed short base and analysts sitting nearly $1,000 above the current price.
Stocks in this article
How this article was generated
- Generated
- 2 Aug 2026, 05:02
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowORTEX Alpha signalsORTEX Alpha signalsAnalyst consensus
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.